Bank of America’s VistaGen Therapeutics VTGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.76K | Buy |
3,378
+2,701
| +399% | +$5.4K | ﹤0.01% | 6227 |
|
|
2025
Q1 | $1.69K | Sell |
677
-20,464
| -97% | -$51.1K | ﹤0.01% | 6306 |
|
|
2024
Q4 | $62.4K | Buy |
21,141
+19,331
| +1,068% | +$57K | ﹤0.01% | 5680 |
|
|
2024
Q3 | $5.45K | Buy |
1,810
+1,572
| +661% | +$4.73K | ﹤0.01% | 6068 |
|
|
2024
Q2 | $829 | Sell |
238
-9,891
| -98% | -$34.5K | ﹤0.01% | 6367 |
|
|
2024
Q1 | $53.5K | Sell |
10,129
-9,270
| -48% | -$48.9K | ﹤0.01% | 5626 |
|
|
2023
Q4 | $99.7K | Buy |
19,399
+18,766
| +2,965% | +$96.5K | ﹤0.01% | 5455 |
|
|
2023
Q3 | $3.32K | Buy |
633
+1
| +0.2% | +$5 | ﹤0.01% | 6140 |
|
|
2023
Q2 | $1.18K | Sell |
632
-81,627
| -99% | -$153K | ﹤0.01% | 6328 |
|
|
2023
Q1 | $10.2K | Sell |
82,259
-42,488
| -34% | -$5.27K | ﹤0.01% | 6091 |
|
|
2022
Q4 | $12.8K | Sell |
124,747
-317,617
| -72% | -$32.7K | ﹤0.01% | 6054 |
|
|
2022
Q3 | $67K | Buy |
442,364
+434,508
| +5,531% | +$65.8K | ﹤0.01% | 5706 |
|
|
2022
Q2 | $7K | Sell |
7,856
-147,221
| -95% | -$131K | ﹤0.01% | 6687 |
|
|
2022
Q1 | $192K | Sell |
155,077
-380,257
| -71% | -$471K | ﹤0.01% | 5738 |
|
|
2021
Q4 | $1.04M | Buy |
535,334
+534,498
| +63,935% | +$1.04M | ﹤0.01% | 4488 |
|
|
2021
Q3 | $2K | Sell |
836
-1,480
| -64% | -$3.54K | ﹤0.01% | 6996 |
|
|
2021
Q2 | $7K | Buy |
+2,316
| New | +$7K | ﹤0.01% | 6551 |
|
|
2019
Q4 | – | Sell |
-771
| Closed | -$1K | – | 6452 |
|
|
2019
Q3 | $1K | Buy |
+771
| New | +$1K | ﹤0.01% | 6290 |
|
|
2018
Q3 | – | Sell |
-6
| Closed | – | – | 6612 |
|
|
2018
Q2 | $0 | Buy |
+6
| New | – | ﹤0.01% | 6476 |
|
|
2016
Q4 | – | Sell |
-71
| Closed | – | – | 6430 |
|
|
2016
Q3 | $0 | Sell |
71
-578
| -89% | – | ﹤0.01% | 6462 |
|
|
2016
Q2 | $3K | Buy |
+649
| New | +$3K | ﹤0.01% | 6001 |
|